Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Neuropathology and Experimental Neurology|November 15, 2013
Decreased hypothalamic prohormone convertase expression in huntington disease patientsDaniel J van Wamelen, N Ahmad Aziz, Juan Zhao, et al.
Journal of Parkinson'S Disease|January 2, 2021
Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease: A Structured ReviewKatarzyna Smilowska, Daniel J van Wamelen, Tomasz Pietrzykowski, et al.
Acta Neurologica Scandinavica|August 20, 2020
The Non-Motor Symptoms Scale in Parkinson's disease: Validation and useDaniel J van Wamelen, Pablo Martinez-Martin, Daniel Weintraub, et al.
Brain Pathology (Zurich, Switzerland)|November 26, 2010
Functional increase of brain histaminergic signaling in Huntington's diseaseDaniel J van Wamelen, Ling Shan, N Ahmad Aziz, et al.
Parkinsonism & Related Disorders|March 15, 2019
Slave to the rhythm: Seasonal differences in non-motor symptoms in Parkinson's diseaseDaniel J van Wamelen, Aleksandra M Podlewska, Valentina Leta, et al.
Translational Neurodegeneration|October 13, 2022
Why do 'OFF' periods still occur during continuous drug delivery in Parkinson's disease?Silvia Rota, Daniele Urso, Daniel J van Wamelen, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 10, 2023
The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson's disease: opicapone versus entacaponeValentina Leta, Daniel J van Wamelen, Federico Aureli, et al.
NPJ Parkinson'S Disease|August 2, 2022
Clinical trajectories and biomarkers for weight variability in early Parkinson's diseaseDaniele Urso, Daniel J van Wamelen, Lucia Batzu, et al.
Journal of Neurology|November 1, 2018
Amyloid-β and Parkinson's diseaseEe Wei Lim, Dag Aarsland, Dominic Ffytche, et al.
Pageof 5